Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  KOREA EXCHANGE  >  Samsung Biologics Co Ltd    207940   KR7207940008

SAMSUNG BIOLOGICS CO LTD (207940)
My previous session
Most popular
  Report  
SummaryNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Samsung Biologics : S. Korean stocks close highest in about 3 weeks

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/12/2019 | 03:42am EST

South Korean stocks gained ground on Friday.

The benchmark Korea Composite Stock Price Index (KOSPI) gained 12.29 points, or 0.60 percent, to settle at 2,075.57. Trading volume stood at 372.5 million shares worth 4.5 trillion won (4 billion U.S. dollars).

It was the highest close in about three weeks.

Many of blue-chip stocks ended in positive territory. Market bellwether Samsung Electronics rose 1.8 percent, and leading chemical firm LG Chem added 0.6 percent. Samsung BioLogics, a biopharmaceutical unit of Samsung Group, the country`s biggest family-controlled conglomerate, climbed 1.9 percent.

The state-run power supplier Korea Electric Power Corp. gained 0.7 percent, but memory chip giant SK Hynix dipped 0.3 percent. The biggest mobile operator SK Telecom declined 2.8 percent, and the biggest steelmaker POSCO lost 1.2 percent.

South Korea`s currency finished at 1,116.4 won against the greenback, up 1.9 won from the previous close.

Bond prices ended lower. Yields on the liquid three-year treasury notes added 0.8 basis points to 1.804 percent, and the return on the 10-year government bonds went up 2.8 basis points to 1.992 percent.

(c) 2019 ITP Business Publishing Ltd. All Rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

Stocks mentioned in the article
ChangeLast1st jan.
KOREA ELECTRIC POWER CORPORATION --End-of-day quote.
SAMSUNG BIOLOGICS CO LTD --End-of-day quote.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SAMSUNG BIOLOGICS CO LTD
01/18Samsung Bioepis biosimilar to Roche's Herceptin wins FDA nod
RE
01/12SAMSUNG BIOLOGICS : S. Korean stocks close highest in about 3 weeks
AQ
2018KYUNG NAM PHARM : Samsung too big to kill, Kyung Nam Pharm weak enough to kill?
AQ
2018SAMSUNG BIOLOGICS : Prosecutors raid Samsung BioLogics headquarters
AQ
2018SAMSUNG BIOLOGICS : South Korea launches raid on Samsung firm amid fraud probe
AQ
2018CELLTRION : Regulator inspects Celltrion for book rigging
AQ
2018REPORT : Samsung bio unit raided over 'accounting fraud'
AQ
2018SAMSUNG BIOLOGICS : South Korean prosecutors raid Samsung BioLogics' office in a..
RE
2018SAMSUNG BIOLOGICS : South Korean prosecutors raid Samsung BioLogics' office in a..
RE
2018SAMSUNG BIOLOGICS : Debate over Samsung Biologics delisting heats up
AQ
More news
Financials (KRW)
Sales 2018 520 B
EBIT 2018 67,4 B
Net income 2018 334 B
Finance 2018 339 B
Yield 2018 -
P/E ratio 2018 79,17
P/E ratio 2019 240,87
EV / Sales 2018 50,2x
EV / Sales 2019 36,6x
Capitalization 26 466 B
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 499 444  KRW
Spread / Average Target 25%
EPS Revisions
Managers
NameTitle
Tae-Han Kim Chief Executive Officer & Director
Ho-Yeol Yoon Managing Director & Head-Operations Support
Dong-Joong Kim Director & Head-Management Support
Seok-Woo Jung Outside Director
Byeong-Cheol Yoon Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
SAMSUNG BIOLOGICS CO LTD23 528
JOHNSON & JOHNSON0.03%350 508
PFIZER-2.70%246 674
NOVARTIS5.66%227 840
ROCHE HOLDING LTD.6.16%223 498
MERCK AND COMPANY-0.71%197 291